Affinity Bio Partners, a global clinical research organization dedicated to safe, ethical studies that ensure subjects benefit from the development of new and novel treatments and therapies, announced that it is launching a clinical study for Pennsylvania's medical cannabis patients suffering from diabetic nerve pain. “I am thrilled to be working on...
Read Full StoryIf the content contained herein violates any of your rights, including those of copyright, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com
comments